20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding Age-Related Macular Degeneration: The Role of Angiogenesis Inhibitors Like Anecortave Acetate

Age-related macular degeneration (AMD) remains a leading cause of vision loss, particularly in older adults. The neovascular or 'wet' form of AMD is characterized by abnormal blood vessel growth under the retina, a process known as angiogenesis. Pharmaceutical intermediates that enable the synthesis of angiogenesis inhibitors are therefore critical in developing treatments for this debilitating condition. Anecortave Acetate, a synthetic corticosteroid derivative, was investigated for its angiostatic properties, making it a key example in the research surrounding AMD treatments.

The study of anecortave acetate for age-related macular degeneration focused on its potential to inhibit the growth of these problematic blood vessels. Understanding the anecortave acetate mechanism of action provided insights into how such compounds can interfere with the angiogenic process. Although anecortave acetate did not achieve widespread market approval for AMD, the research conducted provided valuable data on the efficacy and safety of anti-angiogenic therapies. The development of effective treatments for AMD often involves innovative drug delivery systems, and the research into anecortave acetate drug delivery methods, like the posterior juxtascleral depot, contributed to this understanding. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role by supplying the high-quality pharmaceutical intermediates necessary for developing these advanced treatments, supporting the ongoing fight against vision loss caused by AMD.

The ongoing pursuit of better therapies for AMD relies on continuous innovation and rigorous scientific investigation. By providing essential pharmaceutical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. supports researchers and pharmaceutical companies in their efforts to combat diseases like AMD, ensuring that the building blocks for potential life-changing medicines are readily available.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Anecortave Acetate: A Deep Dive into its Potential for Glaucoma Management

Next: The Significance of Pharmaceutical Intermediates in Ocular Drug Delivery Innovations

All Rights Reserved